Clinical Trial Update: Rosiglitazone-Metformin Combination Versus Metformin-Sulfonylurea Combination On Beta-Cell Function In Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 trial comparing rosiglitazone–metformin versus metformin–sulfonylurea examined beta-cell function in Type 2 Diabetes Mellitus; results were posted on 20…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Rosiglitazone (rosiglitazone)
• Sulfonylurea (class)
• metformin (metformin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: COMPLETED | Results posted: 2009-11-05